JOMPAC
Journal of Medicine and Palliative Care

Journal of Medicine and Palliative Care (JOMPAC) is an open access scientific journal with independent, unbiased, and double-blind review under international guidelines. The purpose of JOMPAC is to contribute to the literature by publishing articles on health sciences and medicine.

eISSN: 2717-7505
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Which factors are predicting the mortality in patients with COVID-19 in the intensive care unit?
Abstract
Aims: COVID-19 infection is a global health problem; clinical and laboratory parameters have been developed to predict this disease-related mortality/morbidity. Some of these parameters are clinical parameters, while some are laboratory parameters. This study aims to determine whether Acute Physiology and Chronic Health Evaluation (APACHE) II, Glasgow Coma Scale (GCS), age, presence of comorbidity, and absolute lymphocyte count effectively predict mortality in patients admitted to intensive care unit (ICU) due to COVID-19.
Methods: We have included 108 PCR-positive COVID-19 patients admitted to the ICU between 1 October and 31 November 2020 in our research. Demographic characteristics of all patients, APACHE II values within the first 24 hours of admission to ICU, the GCS, the presence of comorbidity, lymphocyte count during ICU admission, duration of ICU stay, and the mortality rates were recorded.
Results: The average age of 108 individuals evaluated in the study was 67±13.61 years, and 56.5% of the patient group consisted of the geriatric age range. Seventy (64.8%) of the patients were female, eighty-nine (82.4%) patients had at least one comorbidity. In the multivariate analysis, it was determined that lymphocyte value, APACHE II score, and the presence of any comorbidity are independent prognostic factors for mortality when accepted to ICU.
Conclusion: In our study, we have determined that age, APACHE II value, presence of comorbidity, and baseline lymphocyte counts are independent predictors of mortality.

Keywords : Mortality, COVID-19, intensive care unit

Download Article


1. Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses. 2020;12(2):135. doi:10.3390/v12020135
2. Immovilli P, Morelli N, Antonucci E, Radaelli G, Barbera M,Guidetti D. COVID-19 mortality and ICU admission: the Italianexperience. Crit Care. 2020;24(1):228. doi:10.1186/s13054-020-02957-9
3. Mejdoubi M, Kyndt X, Djennaoui M. ICU admissions and in-hospital deaths linked to COVID-19 in the Paris region arecorrelated with previously observed ambient temperature. PLoSOne. 2020;15(11):e0242268. doi:10.1371/journal.pone.0242268
4. Girgin S, Aksun M, Tüzen AS, et al. Effects of comorbiditiesassociated with COVID-19 cases in Intensive Care Unit onmortality and disease progression. Eur Rev Med Pharmacol Sci.2023;27(8):3753-3765. doi:10.26355/eurrev_202304_32174
5. Zhang X, Li S, Niu S. ACE2 and COVID-19 and the resultingARDS. Postgrad Med J. 2020;96(1137):403-407. doi:10.1136/postgradmedj-2020-137935
6. Lee H, Lim CW, Hong HP, et al. Efficacy of the APACHE II scoreat ICU discharge in predicting post-ICU mortality and ICUreadmission in critically ill surgical patients. Anaesth IntensiveCare. 2015;43(2):175-186. doi:10.1177/0310057X1504300206
7. Lippi G, Plebani M. Laboratory abnormalities in patients withCOVID-2019 infection. Clin Chem Lab Med. 2020;58(7):1131-1134. doi:10.1515/cclm-2020-0198
8. Fan BE, Chong VCL, Chan SSW, et al. Hematologic parametersin patients with COVID-19 infection. Am J Hematol.2020;95(6):E131-E134. doi:10.1002/ajh.25774
9. Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H.Laboratory findings in COVID-19 diagnosis and prognosis. ClinChim Acta. 2020;510:475-482. doi:10.1016/j.cca.2020.08.019
10. Vallipuram T, Schwartz BC, Yang SS, Jayaraman D, Dial S.External validation of the ISARIC 4C Mortality Score to predictin-hospital mortality among patients with COVID-19 in aCanadian intensive care unit: a single-centre historical cohortstudy. Can J Anaesth. 2023;70(8):1362-1370. doi:10.1007/s12630-023-02512-4
11. Moreno RP, Nassar AP Jr. Is APACHE II a useful tool forclinical research?. O APACHE II é uma ferramenta útil parapesquisa clínica?. Rev Bras Ter Intensiva. 2017;29(3):264-267.doi:10.5935/0103-507X.20170046
12. Zimmerman JE, Kramer AA, McNair DS, Malila FM. AcutePhysiology and Chronic Health Evaluation (APACHE) IV: hospitalmortality assessment for today's critically ill patients. Crit Care Med.2006;34(5):1297-1310. doi:10.1097/01.CCM.0000215112.84523.F0
13. Wendel Garcia PD, Fumeaux T, Guerci P, et al. Prognostic factorsassociated with mortality risk and disease progression in 639critically ill patients with COVID-19 in Europe: Initial reportof the international RISC-19-ICU prospective observationalcohort. E Clinical Medicine. 2020;25:100449. doi:10.1016/j.eclinm.2020.100449
14. Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristicsand Outcomes of 1591 Patients Infected With SARS-CoV-2Admitted to ICUs of the Lombardy Region, Italy. JAMA.2020;323(16):1574-1581. doi:10.1001/jama.2020.5394
15. Zou X, Li S, Fang M, et al. Acute Physiology and ChronicHealth Evaluation II Score as a Predictor of Hospital Mortalityin Patients of Coronavirus Disease 2019. Crit Care Med.2020;48(8):e657-e665. doi:10.1097/CCM.0000000000004411
16. Fällmar D, Rostami E, Kumlien E, et al. The extent ofneuroradiological findings in COVID-19 shows correlationwith blood biomarkers, Glasgow coma scale score and days inintensive care. J Neuroradiol. 2022;49(6):421-427. doi:10.1016/j.neurad.2021.11.003
17. Veiga VC, Cavalcanti AB. Age, host response, andmortality in COVID-19. Eur Respir J. 2023;62(1):2300796.doi:10.1183/13993003.00796-2023
18. Miller EJ, Linge HM. Age-related changes in immunological andphysiological responses following pulmonary challenge. Int J MolSci. 2017;18(6):1294. doi:10.3390/ijms18061294
19. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of criticallyill patients with SARS-CoV-2 pneumonia in Wuhan, China: asingle-centered, retrospective, observational study. Lancet RespirMed. 2020;8(5):475-481. doi:10.1016/S2213-2600(20)30079-5
20. Zhou F, Yu T, Du R, et al. Clinical course and risk factors formortality of adult inpatients with COVID-19 in Wuhan, China:a retrospective cohort study. Lancet. 2020;395(10229):1054-1062.doi:10.1016/S0140-6736(20)30566-3
21. Wu C, Chen X, Cai Y, et al. Risk Factors Associated WithAcute Respiratory Distress Syndrome and Death in PatientsWith Coronavirus Disease 2019 Pneumonia in Wuhan,China. JAMA Intern Med. 2020;180(7):934-943. doi:10.1001/jamainternmed.2020.0994
22. Du RH, Liang LR, Yang CQ, et al. Predictors of mortality forpatients with COVID-19 pneumonia caused by SARS-CoV-2:a prospective cohort study. Eur Respir J. 2020;55(5):2000524.doi:10.1183/13993003.00524-2020
23. Sabanoglu C, Inanc IH, Polat E, Peker SA. Long-term predictivevalue of cardiac biomarkers in patients with COVID-19infection. Eur Rev Med Pharmacol Sci. 2022;26(17):6396-6403.doi:10.26355/eurrev_202209_29667
24. Chen N, Zhou M, Dong X, et al. Epidemiological and clinicalcharacteristics of 99 cases of 2019 novel coronavirus pneumonia inWuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. doi:10.1016/S0140-6736(20)30211-7
25. Huang C, Wang Y, Li X, et al. Clinical features of patientsinfected with 2019 novel coronavirus in Wuhan, China. Lancet.2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
26. Frater JL, Zini G, d'Onofrio G, Rogers HJ. COVID-19 and theclinical hematology laboratory. Int J Lab Hematol. 2020;42 Suppl1(Suppl 1):11-18. doi:10.1111/ijlh.13229
27. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a groupof patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ.2020;368:m606. doi:10.1136/bmj.m606
28. Buoro S, Di Marco F, Rizzi M, et al. Papa Giovanni XXIIIBergamo Hospital at the time of the COVID-19 outbreak: Letterfrom the warfront…. Int J Lab Hematol. 2020;42 Suppl 1:8-10.doi:10.1111/ijlh.13207
Article available in :
Volume 4, Issue 4, 2023
Page : 368-372
https://doi.org/10.47582/jompac.1333211
Article Information
Received : 26 Tem 2023
Accepted : 30 Ağu 2023
Published : 30 Ağu 2023
Corresponding Author :

Semih Aydemir: Department of Anesthesiology and Reanimation, Yıldırım Beyazıt University Yenimahalle Training and Research Hospital, Ankara, Turkiye

[email protected]
Citation : Parpucu M, Turan S, Cankar Dal H, et al. Which factors are predicting the mortality in patients with COVID-19 in the intensive care unit?. J Med Palliat Care. 2023;4(4):368-372.

Read: 215
Cited: 1
Download : 159
_Footer